Results for: new+jersey+drugmaker

Health care M&A leads global deal surge

Missouri AG: State could make lethal injections

AbbVie sours on $55B Shire deal after tax changes

Actavis, Warner Chilcott discussing combination

NJ drugmaker pleads to criminal charges

Merck 3Q adjusted profit tops analysts' estimates

Merck to cut 8,500 more jobs

US drugmaker AbbVie wins Dublin's Shire with $55 billion deal

Allergan agrees to $66 billion Actavis offer Valeant walks

US stocks close mixed on uneven economic signals

Bayer to buy Merck consumer business for $14.2B

Pfizer 3Q profit falls 14 pct on generic Lipitor

Pfizer's animal health unit, Zoetis, soars in IPO

Elan buys back $1B shares for $11.25 a share

Stocks climb for week as stimulus bets offset Ukraine tensions

Novartis ordered to face U.S. lawsuit over doctor kickbacks